Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Not all neonicotinoids are the same, study finds
Bee on a flower
Researchers tested 75 bee colonies at five separate locations in Scotland.
Both imidacloprid and thiamethoxam exhibit toxicity, but not clothiandin

New research conducted by the University of Dundee has revealed that not all neonicotinoids are the same.

There has been growing concern over the risk to bee populations from neonicotinoid insecticides and their long-term consequences to the ecosystem and food security.

But a new study shows that one neonicotinoid - clothianidin - does not show the same detrimental effects on bee colonies as its close chemical relatives imidacloprid and thiamethoxam. All three have been subjected to EU-wide bans on their use.

Study leader Dr Chris Connolly, reader in division of neurosciece at Dundee's School of Medicine, said: “Our knowledge of the risk of neonicotinoids to bees is based on studies of imidacloprid and thiamethoxam and these findings have generally been extrapolated to clothianidin.

“However, in this study we have looked at the three neonicotinoids in parallel. What we have found is that imidacloprid and thiamethoxam, but not clothiandin, exhibit toxicity to bumblebee colonies when exposed at field-relevant levels.

“There was also further variation in the effects on bees between the three insecticides. So we can clearly see that the banned neonicotinoids are not the same, so they should be considered independently when considering risk and legislation.

“From our findings, we consider that it is premature to place a permanent ban on the use of clothianidin. That said, a moratorium on its use should continue until the knowledge gaps are filled on its wider impact on other species.”

In the study researchers tested 75 bee colonies at five separate locations in Scotland.

Dr Connolly says that the study once again confirms the threat to bumblebees from imidacloprid and thiamethoxam.

“We have seen further evidence to indicate the risk from these insecticides, including deficits in colony strength,” he said.

“Given these findings, small changes in the pesticide structure or its target site in insects are likely to be critical to risk assessment and each pesticide/insect combination needs to be considered independently - evidence should not be extrapolated to similar chemicals or insects. Real risk must be determined empirically.”

The results of the study are published in the journal Scientific Reports.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
BSAVA publishes fifth Manual of Canine and Feline Neurology

The BSAVA has published the fifth edition of its BSAVA Manual of Canine and Feline Neurology.

The new edition has been reviewed and updated, including new developments in diagnostics, therapeutic approaches and clinical decision-making. It is structured to support clinicians through diagnosis, treatment and long-term management.

The guide features five new chapters covering acute myelopathies, chronic myelopathies, emergency protocols, neurotoxicology and neuro-oncology.

It also includes over 100 videos, including demonstrations of neurological examinations, clinical presentations and diagnostic procedures.

Nicola Lloyd, publishing manager, said: "Whether you're a general practitioner seeking practical guidance, or a specialist aiming to refine your expertise, this edition remains an indispensable reference for anyone involved in the care of neurologically compromised dogs and cats."